ASLAN Pharmaceuticals (ASLN) Q2 2023 Earnings

11AugConfirmed
Aug 22
Oct 22
Q1 2023
Q2 2023
-0.87
-0.58
-0.29
-0

Details

Expected EPS
-0.87
Actual EPS
-0.11
Surprise EPS
0.76
Surprise Percent
+87.36%

Description

ASLAN Pharmaceuticals (ASLN) has reported earnings of -0.11 per share for Q2 2023.

0 Comments

Share your thoughts